Pallas Health

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Compounded semaglutideCompounded · not FDA-approved
• Compounded tirzepatideCompounded · not FDA-approved
• Brand-name FDA-approved GLP-1 medicationsFDA-approved
• NAD+ nasal spray and injectionCompounded · not FDA-approved
• SermorelinCompounded · not FDA-approved

What they publish

Pallas Health publishes 9 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

None — states the plan price includes provider care, ongoing check-ins and care-team messaging with no separate membership fee (as published)

Medication cost

Compounded semaglutide published at $139 for the first month, then $597 every twelve weeks, described as a $199 monthly average. Compounded tirzepatide at $179 for the first month, then $897 every twelve weeks, a $299 monthly average. States the compounded price does not increase with dose. Brand-name medication is billed at pharmacy cash-pay rates, with figures of $1,349, $1,299 and $1,069 per month published against branded products. NAD+ published at $79 or $89 first month then $567 or $597 every twelve weeks; sermorelin at $89 then $597 every twelve weeks (as published)

Introductory offer

Advertises a first month from $139 across the compounded plans.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

States all plans are FSA and HSA eligible.

Consultation process

Online review by a US-licensed clinician, who prescribes only when clinically appropriate. States ongoing check-ins and care-team messaging are included in the plan price.

Eligibility

States medication ships only when a clinician prescribes it, and that certain conditions rule out some treatments. Clinical criteria such as a BMI threshold were not published on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

States it does not manufacture or compound medication itself, and that compounded medications are prepared by US-licensed compounding pharmacies. The pharmacies are not named. Notes the medication you receive may differ in appearance from product images shown.

Shipping

States free expedited, discreet shipping on every plan.

Support services

States ongoing check-ins and care-team messaging are included in every plan price.

Cancellation

States you can cancel at any time with no hidden fees.

Refunds

States that if a clinician decides treatment is not right for you, you are refunded in full.

What stands out

• Publishes brand-name cash-pay figures — $1,349, $1,299 and $1,069 a month — next to its own compounded rates, so the comparison is visible rather than implied.
• Bills compounded plans in twelve-week blocks but publishes the monthly average alongside the block price, which makes it comparable with monthly competitors without arithmetic.
• States the compounded price does not rise with dose, and contrasts that directly with programmes that charge more at higher doses.
• Refunds in full if a clinician declines to prescribe.
• States plainly that it does not manufacture or compound medication itself, and that what arrives may look different from the images on the site.
• On its NAD+ and sermorelin pages it states the research is still developing — a hedge most sellers of those products avoid.
• The first-month price of $139 is well below the ongoing $199 average, so the entry figure is promotional.
• The compounding pharmacies are not named.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• After the first month you are billed $597 or $897 in twelve-week blocks. What is refundable if you stop inside a block?
• Which compounding pharmacy prepares the medication?
• For the brand-name route, the published cash prices are over $1,000 a month. Is insurance or a manufacturer channel a better path for you?
• What clinical criteria apply, given none are published?
• Is baseline lab work expected?
• Compounded medication is not FDA-approved. Do you understand what that means for oversight and recourse?

Frequently asked